Ask a Patient® Health News: Drugs & Treatments

Ask a Patient® Health News: Drugs & Treatments

Share this post

Ask a Patient® Health News: Drugs & Treatments
Ask a Patient® Health News: Drugs & Treatments
November 12, 2023: Zepbound, Cosentyx, Keytruda, Stelara "generic," Inderal and hypoglycemia; CRISPR treatment potential; anxiety herb; questioning osteoporosis drug treatments for reducing fractures
Copy link
Facebook
Email
Notes
More

November 12, 2023: Zepbound, Cosentyx…

Nov 12, 2023

Share this post

Ask a Patient® Health News: Drugs & Treatments
Ask a Patient® Health News: Drugs & Treatments
November 12, 2023: Zepbound, Cosentyx, Keytruda, Stelara "generic," Inderal and hypoglycemia; CRISPR treatment potential; anxiety herb; questioning osteoporosis drug treatments for reducing fractures
Copy link
Facebook
Email
Notes
More

In the first two weeks of November, the FDA made four major drug approvals and reported on two significant drug label changes.

Read →
Comments
User's avatar
© 2025 AskaPatient.com
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More